Since our establishment in 2008, Health Economics and Outcomes Research (HEOR) has grown into one of our primary project areas. Our HEOR specialists provide valuable insight to our clients’ product development and business strategy, with the end goal of improving the cost, quality and accessibility of health care services.

HEOR areas of focus include:

  • Cost-modeling of chronic disease progression and treatment
  • Value-based reimbursement models
  • Estimation of market parameters
  • Product cost-comparison
  • Cost-effectiveness modeling
  • Socioeconomic impact assessment
  • Health economic analysis on administrative claims and EMR databases
  • Systematic reviews and synthesis of epidemiological/clinical outcomes

Representative Projects Include:

Conducted treatment pattern studies examining the sequence of medication and treatment within a patient population as a disease progresses.

Analyzed claims from an all-payer claims database to develop value-based reimbursement model recommendations for shared savings initiatives.

Conducted a health economics assessment of opioid overdose events and resulting healthcare costs using medical claims data and mathematical modeling.

Estimated market parameters and developed cost-effectiveness models for a biologic agent to support a “Go/No-Go” decision early in product development.

Conducted a Monte Carlo health economics simulation of a clinical decision support tool to match patients to the right statin at the beginning of treatment.

Developed long-term annuity-based reimbursement models for high-cost, curative biotechnology interventions.

Executed data analytics for post-market products to demonstrate efficacy, safety, and cost-effectiveness.

Analyzed pharmacy claims for three million patients to determine impact of innovative pharmaceutical packaging designed to improve medication adherence.

Health economics assessment of a CDSS to match patient to the right drug at beginning of treatment.